UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical Reappraisal

Reviews in cardiovascular medicine, 2023-07, Vol.24 (7), p.202

Fragasso, Gabriele

2023

Volltextzugriff (PDF)

Severe Left Ventricular Dysfunction After Acute Myocardial Infarction: A Call for Development of Adequately Targeted Treatments

The American journal of cardiology, 2023-08, Vol.200, p.213-214

Fragasso, Gabriele

2023

Volltextzugriff (PDF)

Applying guidelines directed medical therapy for heart failure: the cardiologist hard job

Trends in cardiovascular medicine, 2024-11

Fragasso, Gabriele

2024

Volltextzugriff (PDF)

Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure

International journal of cardiology, 2016-01, Vol.203, p.909-915

2016

Volltextzugriff (PDF)

Editorial Commentary: Drug dosing optimization in heart failure: Need of a multidimensional approach (and skilled heart failure specialists)

Trends in cardiovascular medicine, 2021-02, Vol.31 (2), p.117-118

Fragasso, Gabriele

2021

Volltextzugriff (PDF)

Metabolic Approaches for the Treatment of Dilated Cardiomyopathy

Journal of cardiovascular development and disease, 2023-07, Vol.10 (7), p.287

2023

Volltextzugriff (PDF)

Editorial commentary: Pathophysiological effects of proton pump inhibitors in cardiac patients: Time for a critical reappraisal

Trends in cardiovascular medicine, 2019-08, Vol.29 (6), p.361-362

Fragasso, Gabriele

2019

Volltextzugriff (PDF)

Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?

Heart (British Cardiac Society), 2018-01, Vol.104 (2), p.88-89

Fragasso, Gabriele

2018

Volltextzugriff (PDF)

Heart or Mind? Unexplained Chest Pain in Patients with and Without Coronary Disease

Heart and Mind, 2018-01, Vol.2 (1), p.5-11

2018

Volltextzugriff (PDF)

Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities

Expert opinion on therapeutic targets, 2022-07, Vol.26 (7), p.633-644

2022

Volltextzugriff (PDF)

Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension

Indian heart journal, 2017-05, Vol.69 (3), p.417-417

2017

Volltextzugriff (PDF)

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID‐19

HemaSphere, 2023-08, Vol.7 (S3), p.e7303650-n/a

2023

Volltextzugriff (PDF)

Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy

The American journal of cardiology, 2016-05, Vol.117 (10), p.1558-1561

2016

Volltextzugriff (PDF)

The origin of the popular iconic heart symbol: fiction or facts?

Journal of visual communication in medicine, 2023-10, Vol.46 (4), p.192-196

2023

Volltextzugriff (PDF)

Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation

International journal of cardiology. Heart & vasculature, 2016-06, Vol.11 (C), p.90-98

2016

Volltextzugriff (PDF)

'Heart Team' decision-making for cardiac interventional procedures should take into account patients' cognitive function and frailty

Journal of cardiovascular medicine (Hagerstown, Md.), 2016-12, Vol.17 (12), p.903-904

Fragasso, Gabriele

2016

Volltextzugriff (PDF)

Effects of metabolic approach in diabetic patients with coronary artery disease

Current pharmaceutical design, 2009-03, Vol.15 (8), p.857-862

2009

Volltextzugriff (PDF)

Metabolic therapy of heart failure

Current pharmaceutical design, 2008-09, Vol.14 (25), p.2582-2591

2008

Volltextzugriff (PDF)

Different Metabolic Effects of Selective and Nonselective Beta-Blockers Rather Than Mere Heart Rate Reduction May Be the Mechanisms by Which Beta-Blockade Prevents Cardiovascular Events

Journal of the American College of Cardiology, 2009-06, Vol.53 (22), p.2105-2105

2009

Volltextzugriff (PDF)

Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men

The American heart journal, 2011-07, Vol.162 (1), p.136-141

2011

Volltextzugriff (PDF)

Cardiotoxicity after low-dose chloroquine antimalarial therapy

Heart and vessels, 2009-09, Vol.24 (5), p.385-387

2009

Volltextzugriff (PDF)

Current experimental and early investigational agents for cardiac fibrosis: where are we at?

Expert opinion on investigational drugs, 2024-04, Vol.33 (4), p.389-404

2024

Volltextzugriff (PDF)

Comparison of Exercise Electrocardiography, Technetium-99m Sestamibi Single Photon Emission Computed Tomography, and Dobutamine and Dipyridamole Echocardiography for Detection of Coronary Artery Disease in Hypertensive Women

The American journal of cardiology, 2010-05, Vol.105 (9), p.1254-1260

2010

Volltextzugriff (PDF)

Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure

Heart (British Cardiac Society), 2020-12, Vol.106 (24), p.1934-1939

2020

Volltextzugriff (PDF)

Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure

Cardiac failure review, 2016-05, Vol.2 (1), p.8-13

Fragasso, Gabriele

2016

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical Reappraisal

Severe Left Ventricular Dysfunction After Acute Myocardial Infarction: A Call for Development of Adequately Targeted Treatments

Applying guidelines directed medical therapy for heart failure: the cardiologist hard job

Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure

Editorial Commentary: Drug dosing optimization in heart failure: Need of a multidimensional approach (and skilled heart failure specialists)

Metabolic Approaches for the Treatment of Dilated Cardiomyopathy

Editorial commentary: Pathophysiological effects of proton pump inhibitors in cardiac patients: Time for a critical reappraisal

Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?

Heart or Mind? Unexplained Chest Pain in Patients with and Without Coronary Disease

Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities

Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID‐19

Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy

The origin of the popular iconic heart symbol: fiction or facts?

Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation

'Heart Team' decision-making for cardiac interventional procedures should take into account patients' cognitive function and frailty

Effects of metabolic approach in diabetic patients with coronary artery disease

Metabolic therapy of heart failure

Different Metabolic Effects of Selective and Nonselective Beta-Blockers Rather Than Mere Heart Rate Reduction May Be the Mechanisms by Which Beta-Blockade Prevents Cardiovascular Events

Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men

Cardiotoxicity after low-dose chloroquine antimalarial therapy

Current experimental and early investigational agents for cardiac fibrosis: where are we at?

Comparison of Exercise Electrocardiography, Technetium-99m Sestamibi Single Photon Emission Computed Tomography, and Dobutamine and Dipyridamole Echocardiography for Detection of Coronary Artery Disease in Hypertensive Women

Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure

Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure

Suchergebnisse filtern